Evaluation of Serum GPX4 Levels and rs713041 Polymorphism in Hypertensive Patients: A Case-Control Study in Dhi Qar Province, Iraq
American Journal of Biology and Natural Sciences · 2025
DOI: 10.51699/ajbns.v2i7.1214 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift American Journal of Biology and Natural Sciences, 2025. Verfasst von Zahraa Suwaih Ghulam und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hypertension is a prevalent cardiovascular condition associated with increased oxidative stress. Glutathione Peroxidase 4 (GPX4) is a critical antioxidant enzyme that protects cells from oxidative damage. This case-control study aimed to assess serum GPX4 levels and the rs713041 T/C polymorphism of the GPX4 gene in hypertensive patients compared to healthy controls in Dhi Qar Province, Iraq. Our findings indicate significantly lower serum GPX4 levels in hypertensive patients, suggesting compromised antioxidant defense mechanisms.
Zitieren
APA
Ghulam, Z. S., & Ahmed, I. H. (2025). Evaluation of Serum GPX4 Levels and rs713041 Polymorphism in Hypertensive Patients: A Case-Control Study in Dhi Qar Province, Iraq. American Journal of Biology and Natural Sciences. https://doi.org/10.51699/ajbns.v2i7.1214
Vancouver
Ghulam ZS, Ahmed IH. Evaluation of Serum GPX4 Levels and rs713041 Polymorphism in Hypertensive Patients: A Case-Control Study in Dhi Qar Province, Iraq. American Journal of Biology and Natural Sciences. 2025. doi:10.51699/ajbns.v2i7.1214
BibTeX
@article{Ghulam2025,
author = {Ghulam, Zahraa Suwaih and Ahmed, Intisar Hussein},
title = {Evaluation of Serum GPX4 Levels and rs713041 Polymorphism in Hypertensive Patients: A Case-Control Study in Dhi Qar Province, Iraq},
journal = {American Journal of Biology and Natural Sciences},
year = {2025},
doi = {10.51699/ajbns.v2i7.1214}
}
EUVIMED